比姆和Mcl-1坐标NVP-BEZ235-诱导的细胞癌细胞亡
Yen-Chuan Ou1, Jian-Ri Li2, Tung-Min Yu3
1Department of Urology, Tungs' Taichung MetroHarbor Hospital, Taichung City, 433, Taiwan.
Archives of biochemistry and biophysics
|July 11, 2025
概括
像NVP-BEZ235这样的双PI3K/mTOR抑制剂通过诱导自和细胞死亡,在细胞癌 (RCC) 中表现出抗瘤作用. 将这些抑制剂与MEK/ERK抑制剂相结合,可以增强抗癌活性,克服抗药性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 在细胞癌 (RCC) 中,PI3K/Akt/mTOR通路经常失调,与侵袭性疾病和不良预后相关.
- 了解PI3K/mTOR双抑制剂的机制对于开发有效的RCC疗法至关重要.
研究的目的:
- 在人类RCC细胞系 (786-O和ACHN) 中研究PI3K/mTOR双抑制剂NVP-BEZ235的抗瘤机制.
- 探索组合策略,以克服对NVP-BEZ235的耐药性,并提高其抗癌疗效.
主要方法:
- 用NVP-BEZ235和各种抑制剂 (Bcl-2,Mcl-1,PI3K,Stat3,MEK/ERK) 治疗RCC细胞.
- 细胞增殖,迁移,细胞亡和自的评估.
- 对关键信号通路组件的分析,包括Akt,FOXO1,ERK,Stat3,Mcl-1和Bim.
- 活体瘤载体研究,以评估组合治疗的疗效和毒性.
主要成果:
- NVP-BEZ235减少了RCC细胞的增殖和迁移,同时诱导了自细胞死亡.
- 由NVP-BEZ235对Akt的非激活导致FOXO1和ERK的激活,以及Stat3的非激活.
- 亡是有限的,但与Bcl-2/Mcl-1抑制剂或PI3K/Stat3抑制剂的组合使细胞对亡敏感.
- 补偿性ERK激活限制了Bim介导的亡,但与MEK/ERK抑制剂的结合显示出体内增强的抗瘤作用,毒性低.
结论:
- 支持生存途径的反激活有助于在RCC中对NVP-BEZ235的抵抗.
- 组合疗法,特别是MEK/ERK抑制剂,是提高RCC细胞敏感度和改善治疗结果的有希望的策略.
相关概念视频
The Intrinsic Apoptotic Pathway
6.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
The Retinoblastoma Gene
4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K


